SHINGLES
Clinical trials for SHINGLES explained in plain language.
Never miss a new study
Get alerted when new SHINGLES trials appear
Sign up with your email to follow new studies for SHINGLES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shingles vaccine shows promise in Head-to-Head trial
⭐️ VACCINE ⭐️ OngoingThis study tests a new shingles vaccine called JCXH-105 in healthy adults aged 50 and older. About 467 participants will receive either JCXH-105 or the current vaccine Shingrix to compare safety and immune response. The goal is to see if the new vaccine can prevent shingles as we…
Matched conditions: SHINGLES
Phase: PHASE2 • Sponsor: Immorna Biotherapeutics, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 06:21 UTC
-
New shingles vaccine shows promise in Head-to-Head trial
⭐️ VACCINE ⭐️ OngoingThis study tests a new shingles vaccine called CRV-101 against the current vaccine, Shingrix, in adults aged 50 and older. The goal is to see if CRV-101 is as safe and triggers a similar immune response. About 1,500 participants will receive either the new vaccine or Shingrix and…
Matched conditions: SHINGLES
Phase: PHASE2 • Sponsor: Curevo Inc • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 06:18 UTC
-
New shingles vaccine shows promise in Mid-Stage trial
⭐️ VACCINE ⭐️ OngoingThis study tests a new vaccine called LYB004 to see if it can safely protect adults aged 40 and older from shingles, a painful rash caused by the chickenpox virus. About 840 participants in China will receive the vaccine and be monitored for side effects and immune response. The …
Matched conditions: SHINGLES
Phase: PHASE2 • Sponsor: Guangzhou Patronus Biotech Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:53 UTC